within Pharmacolibrary.Drugs.ATC.G;

model G03DB06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.85,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.06,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.01,
    Tlag           = 900
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03DB06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Chlormadinone is a synthetic progestin hormone related to progesterone, used primarily as an oral contraceptive component and in some countries for treatment of menopausal symptoms or androgen-dependent conditions. Its use has declined and is largely limited to certain regions, with alternatives being more commonly employed.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult women based on available data and similarities to related progestins, as no definitive, peer-reviewed population pharmacokinetic studies reporting detailed parameters for chlormadinone are accessible.</p><h4>References</h4><ol><li><p>Curran, MP, &amp; Wagstaff, AJ (2004). Ethinylestradiol/chlormadinone acetate. <i>Drugs</i> 64(7) 751–762. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200464070-00005&quot;>10.2165/00003495-200464070-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15025547/&quot;>https://pubmed.ncbi.nlm.nih.gov/15025547</a></p></li><li><p>Terlinden, R, et al., &amp; Kneip, C (2006). Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg) and elimination and clearance of a single dose of radiolabeled chlormadinone acetate. <i>Contraception</i> 74(3) 239–244. DOI:<a href=&quot;https://doi.org/10.1016/j.contraception.2006.03.011&quot;>10.1016/j.contraception.2006.03.011</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16904418/&quot;>https://pubmed.ncbi.nlm.nih.gov/16904418</a></p></li><li><p>Bouchard, P (2005). Chlormadinone acetate (CMA) in oral contraception--a new opportunity. <i>The European journal of contraception &amp; reproductive health care : the official journal of the European Society of Contraception</i> 10 Suppl 1 7–11. DOI:<a href=&quot;https://doi.org/10.1080/13625180500434889&quot;>10.1080/13625180500434889</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16356876/&quot;>https://pubmed.ncbi.nlm.nih.gov/16356876</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03DB06;
